Celecoxib

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain in adults, painful menstruation, and juvenile rheumatoid arthritis in people two years or older.

Side Effects[edit | edit source]

Using nonsteroidal anti-inflammatory precautions is recommended to avoid gastrointestinal side effects. Hepatic and renal dysfunction may occur, and peripheral edema.[1]Central nervous system side effects include "dizziness, headaches, drowsiness and evidence of hypersensitives." [1]

More commonly reported ones are:

  • Gastrointestinal side-effects including bleeding.[1]

More commonly reported ones in children are:


Less commonly reported ones are:

Evidence[edit | edit source]

The Canadian Consensus Criteria suggests Celecoxib for pain in ME/CFS.[1]

Dose[edit | edit source]

A dose of 100mg, as needed, up to twice a day, is suggested by the Canadian Consensus Criteria.[1]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

Adverse reaction - Any unintended or unwanted response to the treatment under investigation in a clinical trial.

Canadian consensus criteria (CCC) - A set of diagnostic criteria used to diagnose ME/CFS, developed by a group of practicing ME/CFS clinicians in 2003. The CCC is often considered to be the most complex criteria, but possibly the most accurate, with the lowest number of patients meeting the criteria. Led to the development of the International Consensus Criteria (ICC) in 2011.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.